In the dimer state, PKM2 has low catalytic activity, which allows cells to accumulate glycolytic intermediates that can not only enter the glycolytic pathway, but also be converted into substrates for other metabolic pathways, thus providing cells with the necessary biosynthetic precursors and energy requirements to promote rapid proliferation and growth of tumor cells [34]. Here, PKM is linked to neoplasm.